<?xml version="1.0" encoding="UTF-8"?>
<bill>
  <bill-type>h</bill-type>
  <blog-article-count type="integer">37</blog-article-count>
  <hot-bill-category-id type="integer" nil="true"></hot-bill-category-id>
  <id type="integer">55690</id>
  <introduced type="integer">1236142800</introduced>
  <is-frontpage-hot type="boolean">false</is-frontpage-hot>
  <last-speech type="integer" nil="true"></last-speech>
  <last-vote-date type="integer" nil="true"></last-vote-date>
  <last-vote-roll type="integer" nil="true"></last-vote-roll>
  <last-vote-where nil="true"></last-vote-where>
  <lastaction type="integer">1236142800</lastaction>
  <news-article-count type="integer" nil="true"></news-article-count>
  <number type="integer">1298</number>
  <page-views-count type="integer">1299</page-views-count>
  <pl nil="true"></pl>
  <plain-language-summary nil="true"></plain-language-summary>
  <rolls nil="true"></rolls>
  <session type="integer">111</session>
  <sponsor-id type="integer">400026</sponsor-id>
  <summary>	3/4/2009--Introduced.Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.</summary>
  <topresident-date type="integer">1236142800</topresident-date>
  <topresident-datetime type="date">2009-03-04</topresident-datetime>
  <updated type="timestamp">Tue Jan 05 20:56:45 -0600 2010</updated>
  <bill-titles type="array">
    <bill-title>
      <as>introduced</as>
      <bill-id type="integer">55690</bill-id>
      <fti-titles>'act':9 'drug':6,17 'food':5 'amend':2 'feder':4 'cosmet':8 'import':14 'purpos':21 'respect':11 'prescript':16</fti-titles>
      <id type="integer">69975</id>
      <is-default type="boolean">false</is-default>
      <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.</title>
      <title-type>official</title-type>
    </bill-title>
    <bill-title>
      <as>introduced</as>
      <bill-id type="integer">55690</bill-id>
      <fti-titles>'act':7 '2009':9 'drug':5 'access':3 'market':2 'safeti':6 'pharmaceut':1</fti-titles>
      <id type="integer">69974</id>
      <is-default type="boolean">false</is-default>
      <title>Pharmaceutical Market Access and Drug Safety Act of 2009</title>
      <title-type>short</title-type>
    </bill-title>
  </bill-titles>
  <last-action>
    <action-type>action</action-type>
    <amendment-id type="integer" nil="true"></amendment-id>
    <bill-id type="integer">55690</bill-id>
    <created-at type="timestamp" nil="true"></created-at>
    <date type="integer">1236142800</date>
    <datetime type="timestamp">Wed Mar 04 00:00:00 -0600 2009</datetime>
    <how nil="true"></how>
    <id type="integer">187015</id>
    <result nil="true"></result>
    <roll-call-id type="integer" nil="true"></roll-call-id>
    <roll-call-number type="integer" nil="true"></roll-call-number>
    <text>Referred to the House Committee on Energy and Commerce.</text>
    <vote-type nil="true"></vote-type>
    <where nil="true"></where>
  </last-action>
  <sponsor>
    <biography nil="true"></biography>
    <bioguideid>B000420</bioguideid>
    <birthday type="date">1942-08-27</birthday>
    <blog-article-count type="integer">2196</blog-article-count>
    <congress-office>2305 Rayburn House Office Building</congress-office>
    <contact-webform>http://www.house.gov/berry/zipauth.shtml</contact-webform>
    <district>1</district>
    <email nil="true"></email>
    <fax>202-225-5602</fax>
    <firstname>Robert</firstname>
    <fti-names>'d':4 '-1':6 'ar':5 'rep':1 'berri':3,8,11 'marion':9 'robert':2,7,10</fti-names>
    <gender>M</gender>
    <id type="integer">400026</id>
    <lastname>Berry</lastname>
    <metavid-id>Marion_Berry</metavid-id>
    <middlename>Marion</middlename>
    <name>Rep. Robert Berry [D, AR-1]</name>
    <news-article-count type="integer">553</news-article-count>
    <nickname>Marion</nickname>
    <osid>N00005455</osid>
    <page-views-count type="integer">8213</page-views-count>
    <party>Democrat</party>
    <phone>202-225-4076</phone>
    <religion>Methodist</religion>
    <state>AR</state>
    <sunlight-nickname>Marion</sunlight-nickname>
    <title>Rep.</title>
    <unaccented-name>Robert Berry</unaccented-name>
    <url nil="true"></url>
    <user-approval type="float">3.08333333333333</user-approval>
    <watchdog-id nil="true"></watchdog-id>
    <website>http://www.house.gov/berry/</website>
    <youtube-id nil="true"></youtube-id>
  </sponsor>
  <co-sponsors type="array"/>
  <actions type="array">
    <action type="BillAction">
      <action-type>action</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">55690</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1236142800</date>
      <datetime type="timestamp">Wed Mar 04 00:00:00 -0600 2009</datetime>
      <how nil="true"></how>
      <id type="integer">187015</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
    <action type="BillAction">
      <action-type>introduced</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">55690</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1236142800</date>
      <datetime type="timestamp">Wed Mar 04 00:00:00 -0600 2009</datetime>
      <how nil="true"></how>
      <id type="integer">187014</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text nil="true"></text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
  </actions>
  <roll-calls type="array"/>
</bill>
